386
Participants
Start Date
October 12, 2017
Primary Completion Date
October 31, 2018
Study Completion Date
October 31, 2018
Bexagliflozin
tablets containing 20 mg bexagliflozin
Sitagliptin
tablets containing 100 mg sitagliptin
Placebo for sitagliptin
inactive tablets to match the appearance of sitagliptin tablets
Placebo for bexagliflozin
inactive tablets to match the appearance of bexagliflozin tablets
Clinical Research Site 9012, Madrid
Clinical Research Site 1031, Port Orange
Clinical Research Site 9011, Seville
Clinical Research Site 9014, Seville
Clinical Research Site 1008, Munroe Falls
Clinical Research Site 9018, Valencia
Clinical Research Site 9005, Alzira
Clinical Research Site 1271, Chicago
Clinical Research Site 1359, Topeka
Clinical Research Site 1360, San Antonio
Clinical Research Site 1358, Long Beach
Clinical Research Site 1361, San Dimas
Clinical Research Site 1357, Lincoln
Clinical Research Site 1009, Berlin
Clinical Research Site 1037, Trenton
Clinical Research Site 3119, Hodonín
Clinical Research Site 3123, Mladá Boleslav
Clinical Research Site 3120, Olomouc
Clinical Research Site 3112, Prague
Clinical Research Site 3122, Prostějov
Clinical Research Site 9102, Balatonfüred
Clinical Research Site 9101, Balatongyörök
Clinical Research Site 9106, Budapest
Clinical Research Site 9107, Szeged
Clinical Research Site 9105, Zalaegerszeg
Clinical Research Site 9103, Zamárdi
Clinical Research Site 9015, Seville
Clinical Research Site 6031, Chiba
Clinical Research Site 6037, Chiba
Clinical Research Site 6042, Chiba
Clinical Research Site 6040, Fukuoka
Clinical Research Site 6035, Fukuoka
Clinical Research Site 6034, Ibaraki
Clinical Research Site 6039, Ibaraki
Clinical Research Site 6041, Ibaraki
Clinical Research Site 6032, Ibaraki
Clinical Research Site 6033, Ōsaka
Clinical Research Site 6036, Shizuoka
Clinical Research Site 6038, Tochigi
Clinical Research Site 7137, Gdansk
Clinical Research Site 7144, Krakow
Clinical Research Site 7142, Krakow
Clinical Research Site 7139, Krakow
Clinical Research Site 7141, Krakow
Clinical Research Site 7120, Lublin
Clinical Research Site 7138, Lublin
Clinical Research Site 7131, Olsztyn
Clinical Research Site 7143, Poznan
Clinical Research Site 7140, Poznan
Clinical Research Site 7136, Poznan
Clinical Research Site 7107, Puławy
Clinical Research Site 7128, Torun
Clinical Research Site 9002, Alicante
Clinical Research Site 9016, Almería
Clinical Research Site 9017, Barcelona
Clinical Research Site 9013, Barcelona
Lead Sponsor
Theracos
INDUSTRY